VeriMompolyvinylacetamide hamilelikte güvenli mi?
No harmonised CLP classification, no SCCS or CIR reproductive safety opinion located, and no peer‑reviewed evidence of reproductive or teratogenic effects of poly(N‑vinylacetamide) or its use in cosmetics was found. Regulatory/INCI sources treat this as a polymer (polymer concerns typically focus on residual monomer). Sources searched showed INCI entries and substance pages but no harmonised flags or safety assessments for reproductive endpoints. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
Related ingredients
Frequently asked questions
- polyvinylacetamide hamilelikte güvenli mi?
- No harmonised CLP classification, no SCCS or CIR reproductive safety opinion located, and no peer‑reviewed evidence of reproductive or teratogenic effects of poly(N‑vinylacetamide) or its use in cosmetics was found. Regulatory/INCI sources treat this as a polymer (polymer concerns typically focus on residual monomer). Sources searched showed INCI entries and substance pages but no harmonised flags or safety assessments for reproductive endpoints. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
- polyvinylacetamide emzirirken güvenli mi?
- No data found showing transfer to breast milk or adverse effects during lactation for polyvinylacetamide. No authoritative safety assessment (CIR/SCCS/harmonised CLP) raising reproductive/lactation concerns was identified; therefore default scoring is 0. Potential concern would relate to residual monomer (N‑vinylacetamide) if present, but no data on levels or breast‑milk transfer were located. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
- polyvinylacetamide bebek cildi için güvenli mi?
- No evidence of developmental or infant‑specific hazard was found. For exposure (e) infants have a less mature skin barrier and higher surface‑area‑to‑weight ratio; polymers like poly(N‑vinylacetamide) are generally of low dermal absorption, so adult exposure is negligible (e=0) but infant exposure is increased to e=1 to reflect higher potential per‑weight exposure and possibility of measurable absorption if small amounts of low‑molecular‑weight species (residual monomer) are present. There is no infant‑specific toxicology showing increased hazard. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Poly%28N-vinylacetamide%29?utm_source=openai))
- VeriMom polyvinylacetamide nasıl puanlıyor?
- VeriMom polyvinylacetamide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte polyvinylacetamide yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.